Clinical data | |
---|---|
Other names | CK-274 |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
Chemical and physical data | |
Formula | C18H19N5O2 |
Molar mass | 337.383 g·mol−1 |
3D model (JSmol) | |
| |
|
Aficamten (CK-274) is a cardiac myosin inhibitor[1] developed by Cytokinetics for the treatment of obstructive hypertrophic cardiomyopathy.[2][3][4]